US · guidance
CMS Pub. 100-16, ch. 5, § 10
Introduction
In early 2010, the Centers for Medicare & Medicaid Services (CMS) developed a Quality
Improvement Strategy for the Medicare Advantage (MA) and Prescription Drug Plan (PDP)
Programs based on the 2001 Institute of Medicine (IOM) report. That strategy was expanded in
2011 to reflect the Department of Health and Human Services’ (HHS) National Strategy for
Quality Improvement in Health Care.
Based on the HHS strategy and the Affordable Care Act, HHS developed the National Quality
Strategy (NQS) and the National Prevention Strategy (NPS) and CMS developed and released in
June, 2012 its MA and PDP Quality Strategy, entitled “Medicare Advantage and Prescription
Drug Plan Quality Strategy: A Framework for Improving Care for Beneficiaries.” CMS’ MA and
PDP Quality Strategy was the culmination of a coordinated staff effort and leadership across
CMS.
The MA and PDP Quality Strategy is expected to serve as a framework to advance CMS’
continuous quality improvement efforts, establish a culture of improving quality of care and
services in the MA and PDP programs and improve the quality of care for Medicare beneficiaries
enrolled in those programs.
The MA and PDP Quality Strategy include a vision, mission, five core values, and six goals as
outlined below. The vision is to ensure that Medicare beneficiaries enrolled in MAOs receive
efficient, high quality care and services every time. The mission is to lead and develop the
infrastructure, tools, and performance measures for MAOs to provide integrated coordinated care and
the best services for every beneficiary across all plan types. The five core values are Robust,
Consumer Friendly, Comparable, Comprehensive, and Transparent. These core values provide the
necessary foundation in support of the MA and PDP Quality Strategy. Specific MA and PDP Quality
Strategy goals are as follows:
1. Build Solid and Dedicated Medicare Leadership and Infrastructure;
2. Foster Communications and Partnerships Across All Levels of Government;
3. Lead the Health Care Industry in Providing Cutting Edge, Integrated Coordinated Care;
4. Monitor and Assess the Quality of Health Care Services;
5. Provide Incentives for Improving and/or Excelling on Quality Assessments; and,
6. Improve Beneficiaries’ Ability to Use Quality Measures to Evaluate and Compare Health
Plans and Services
The MA and PDP Quality Strategy’s vision, mission, core values, and goals collectively drive the
quality of healthcare and ongoing quality improvement initiatives for all plans.
All Medicare Advantage Organizations (MAOs) are required, as a condition of their contract
with CMS, to develop a Quality Improvement program that is based on care coordination for
enrollees. The MA and PDP Quality Strategy support that requirement by providing a framework
for MAOs and PDPs as they work to improve care and patient health outcomes. The foundation
of the MA and PDP Quality Strategy and the Quality Improvement program is improving care
coordination and encouraging provision of health care using evidence-based clinical protocols.
The complete MA and PDP Quality Strategy report, as well as other pertinent MA quality-related documents, are available on the CMS MA Quality Web site located at:
http://www.cms.gov/Medicare/Health-Plans/Medicare-Advantage-Quality-Improvement-Program/Overview.html. Please note that this Chapter does not address quality requirements for
stand-alone PDPs. Guidance on standalone PDP quality requirements can be found in Chapter
7of the Prescription Drug Manual at: https://www.cms.gov/Medicare/Prescription-Drug-
Coverage/PrescriptionDrugCovContra/downloads/Chapter7.pdf.
History
(Rev. 117, Issued: 08-08-14, Effective: 08-08-14, Implementation: 08-08-14)
Provenance
- Source
- cms.gov
- Retrieved
- 2026-08-25
- Edition
- iom-2026-08-25
- Content hash
772bafcdeb97435b73fb743a012d9ff54a2ab0917c519c38d206f32c511a5b3d
The link goes to the issuing authority’s own document — the one we read to produce this record. Where a source publishes whole titles rather than sections, your browser may need a moment to jump to the provision.
Unofficial copy of government-published law, reproduced from official sources with full provenance. Not an official publication; verify against official sources before relying on it in a filing. Records in the 'guidance' corpus, and only that corpus, are sub-regulatory (interpretive guidelines, survey procedures) and are not binding law. Validity bounds follow each jurisdiction's declared temporalBasis.